Genes and attention-deficit hyperactivity disorder

J Swanson, C Deutsch, D Cantwell, M Posner… - Clinical Neuroscience …, 2001 - Elsevier
In a collaborative research program on attention-deficit hyperactivity disorder (ADHD)
initiated 20 years ago at UC Irvine, we adopted Cantwell's (1994) approach to define a …

An auditable protocol for treating attention deficit/hyperactivity disorder

P Hill, E Taylor - Archives of disease in childhood, 2001 - adc.bmj.com
We present an auditable protocol for attention deficit/hyperactivity disorder (ADHD) or
hyperkinetic disorder. The protocol is derived from standard recommendations and …

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

JM Swanson, HC Kraemer, SP Hinshaw… - Journal of the American …, 2001 - Elsevier
OBJECTIVES: To develop a categorical outcome measure related to clinical decisions and
to perform secondary analyses to supplement the primary analyses of the NIMH …

[PDF][PDF] Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain

ND Volkow, GJ Wang, JS Fowler, J Logan… - The Journal of …, 2001 - Soc Neuroscience
Methylphenidate (Ritalin) is the most commonly prescribed psychoactive drug in children for
the treatment of attention deficit hyperactivity disorder (ADHD), yet the mechanisms …

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers

PS Jensen, SP Hinshaw, JM Swanson… - … of Developmental & …, 2001 - journals.lww.com
Abstract In 1992, the National Institute of Mental Health and 6 teams of investigators began a
multisite clinical trial, the Multimodal Treatment of Attention-Deficit Hyperactivity Disorder …

How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis

HM Schachter, J King, S Langford, D Moher - Cmaj, 2001 - Can Med Assoc
Background: Numerous small clinical trials have been carried out to study the behaviourally
defined efficacy and safety of short-acting methylphenidate compared with placebo for …

Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder

FX Castellanos, JN Giedd, PC Berquin… - Archives of general …, 2001 - jamanetwork.com
Background Anatomic studies of boys with attention-deficit/hyperactivity disorder (ADHD)
have detected decreased volumes in total and frontal brain, basal ganglia, and cerebellar …

Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial

LL Greenhill, JM Swanson, B Vitiello, M Davies… - Journal of the American …, 2001 - Elsevier
OBJECTIVE: Results of the NIMH Collaborative Multisite Multimodal Treatment Study of
Children With Attention-Deficit/Hyperactivity Disorder (MTA) were analyzed to determine …

Neuropsychological analyses of impulsiveness in childhood hyperactivity

K Rubia, E Taylor, AB Smith, H Oksannen… - The British Journal of …, 2001 - cambridge.org
BackgroundNeuropsychological analyses of impulsiveness are needed to refine
assessment of attention-deficit hyperactivity disorder (ADHD). AimsTo investigate specific …

Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network

S Overmeyer, ET Bullmore, J Suckling… - Psychological …, 2001 - cambridge.org
Background. Previous neuroimaging studies of children with attention deficit hyperactivity
disorder (ADHD) have demonstrated anatomic and functional abnormalities predominantly …